150 The Auditory and Vestibular Manifestations of Charcot Marie-Tooth Disease

1995 ◽  
Vol 113 (2) ◽  
pp. P203-P203
Author(s):  
Daniel R. Fear ◽  
C. Bruce MacDonald ◽  
L. Clarke Cox

Objective: To present the auditory-vestibular manifestations of Charcot Marie-Tooth Disease (CMT). Case Report: A 53-year-old woman complained of progressive imbalance over 1 year. Imbalance was described as the sense that she was about to fall to one side, was exacerbated by rapid head acceleration, and had no relation to postural changes. Symptoms were continuous, and she fell multiple times. She used a cane for 1 year, but for the last month required a walker. Bilateral tinnitus and hearing loss developed over the last year. CMT had been diagnosed about 20 years earlier, with progressive distal limb weakness and wasting and peripheral sensory neuropathy. The neurotologic examination was normal except for the following: There was mild tremor in the left hand. Unsupported stance was unsteady, and she fell with eye closure. Vibrotactile sensation was reduced at the hands and ankles. Audiometry demonstrated a mild, somewhat asymmetric sensorineural hearing loss (SNHL). Auditory brainstem response showed poor waveform morphology bilaterally; however, the latencies for waves III and IV were within the normal range. Electronystagmography with rotary chair data showed hypofunction and reduced vestibulo-ocular gain. Ophthalmologic evaluation was refused. Discussion: CMT is an autosomal-dominant disorder manifested by progressive peripheral neuropathy, resulting in distal muscle atrophy and a peripheral sensory neuropathy. SNHL has been described in CMT. The Rosenberg-Chutorian Syndrome involves CMT with SNHL and optic atrophy. Other cranial neuropathies have also been described in CMT. Results: We describe a patient with CMT patient who had hearing loss and imbalance. The combination of vestibulopathy, sensory (proprioceptive) neuropathy, and muscle atrophy produced a devastating balance disorder. The literature on otologic manifestations of CMT is reviewed.

2018 ◽  
Vol 8 (1) ◽  
Author(s):  
Ji Eun Choi ◽  
Jin Myoung Seok ◽  
Jungmin Ahn ◽  
Yoon Sang Ji ◽  
Kyung Myun Lee ◽  
...  

2020 ◽  
Vol 41 (7) ◽  
pp. 870-880 ◽  
Author(s):  
Glenn B. Pfeffer ◽  
Tyler Gonzalez ◽  
James Brodsky ◽  
John Campbell ◽  
Chris Coetzee ◽  
...  

Background: Charcot-Marie-Tooth (CMT) disease is a hereditary motor-sensory neuropathy that is often associated with a cavovarus foot deformity. Limited evidence exists for the orthopedic management of these patients. Our goal was to develop consensus guidelines based upon the clinical experiences and practices of an expert group of foot and ankle surgeons. Methods: Thirteen experienced, board-certified orthopedic foot and ankle surgeons and a neurologist specializing in CMT disease convened at a 1-day meeting. The group discussed clinical and surgical considerations based upon existing literature and individual experience. After extensive debate, conclusion statements were deemed “consensus” if 85% of the group were in agreement and “unanimous” if 100% were in support. Conclusions: The group defined consensus terminology, agreed upon standardized templates for history and physical examination, and recommended a comprehensive approach to surgery. Early in the course of the disease, an orthopedic foot and ankle surgeon should be part of the care team. This consensus statement by a team of experienced orthopedic foot and ankle surgeons provides a comprehensive approach to the management of CMT cavovarus deformity. Level of Evidence: Level V, expert opinion.


1993 ◽  
Vol 39 (9) ◽  
pp. 1845-1849 ◽  
Author(s):  
G W Hensels ◽  
E A Janssen ◽  
J E Hoogendijk ◽  
L J Valentijn ◽  
F Baas ◽  
...  

Abstract Charcot-Marie-Tooth disease type 1 (CMT1) is a hereditary motor and sensory neuropathy. The autosomal dominant subtype is often linked with a large duplication on chromosome 17p11.2. The gene encoding the peripheral myelin protein PMP 22 (the critical gene in this subtype of CMT1) is located within this duplication. To detect this duplication in chromosomal DNA from individuals thought to have CMT1, we compared the hybridization signals of two DNA probes within this duplication (VAW412R3a and VAW409R3a) with the signal of a reference probe (E3.9). When duplication was present, the signals from the first two probes increased from 100% (for nonduplicated samples) to 145% and 142%, respectively. The day-to-day variance was 3.7% and 5.1%, respectively. We demonstrated this DNA duplication in 49 of 95 DNA samples from unrelated individuals thought to have CMT1. Moreover, because hereditary neuropathy with liability to pressure palsies (HNPP) is based on a DNA deletion in the same area of chromosome 17, this quantitative test may be useful in establishing the presence of HNPP. In a preliminary investigation, four unrelated patients with HNPP yielded test values of 63% and 54%, respectively, of those for nonduplicated samples (CV 19% and 18%, respectively; n = 4), suggesting a deletion in 17p11.2.


CHEST Journal ◽  
1987 ◽  
Vol 91 (4) ◽  
pp. 567-570 ◽  
Author(s):  
Charles K. Chan ◽  
Vahid Mohsenin ◽  
Jacob Loke ◽  
Jim Virgulto ◽  
M. Leonide Sipski ◽  
...  

Neurology ◽  
1993 ◽  
Vol 43 (5) ◽  
pp. 1010-1010 ◽  
Author(s):  
J. E. Hoogendijk ◽  
E.A.M. Janssen ◽  
A. A.W.M. Gabreels-Festen ◽  
G. W. Hensels ◽  
E. M.G. Joosten ◽  
...  

2015 ◽  
Vol 42 (3) ◽  
pp. 249-253 ◽  
Author(s):  
Yukihide Maeda ◽  
Yuko Kataoka ◽  
Akiko Sugaya ◽  
Shin Kariya ◽  
Katsuhiro Kobayashi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document